MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression

Wei Chen(BGI Group (China)), Fangcheng Li(Sun Yat-sen Memorial Hospital)
Oncotarget
February 8, 2017
Cited by 149


Related Papers